Literature DB >> 843876

Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"?

D H Lawson, D A Henry.   

Abstract

Mesh:

Year:  1977        PMID: 843876      PMCID: PMC1605545          DOI: 10.1136/bmj.1.6062.691

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  16 in total

1.  Post-marketing surveillance of adverse reactions to new medicines.

Authors:  A B Wilson
Journal:  Br Med J       Date:  1977-10-15

2.  Once is not enough.

Authors:  F Gross
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

3.  Monitoring adverse reactions to drugs.

Authors:  R Pearson
Journal:  Br Med J       Date:  1977-04-30

Review 4.  Detection of drug-induced disease.

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

5.  After practolol.

Authors: 
Journal:  Br Med J       Date:  1977-12-17

6.  Post-marketing surveillance in the UK (1984).

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

7.  New strategies for drug monitoring.

Authors: 
Journal:  Br Med J       Date:  1977-04-02

8.  Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

9.  Post-marketing drug surveillance.

Authors:  R J Walden; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

10.  Postmarketing surveillance: practical experience with ketotifen.

Authors:  W P Maclay; D Crowder; S Spiro; P Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.